Evidence map›Paper›PMID 32195353›Full record

ArticleScience advances2020

Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.

Yang Liu, Jia Fan, Ting Xu, Navid Ahmadinejad, Kenneth Hess, Steven H Lin, Jianjun Zhang, Xi Liu, Li Liu, Bo Ning and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Pan-cancer Distant Metastasis Prediction Based on Graph Neural Network.Interdisciplinary sciences, computational life sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yang LiuDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0001-6450-9509
Jia FanDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Ting XuDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-7851-3389
Navid AhmadinejadCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.ORCID 0000-0001-8584-0890
Kenneth HessDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Steven H LinDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jianjun ZhangDepartment of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xi LiuMolecular Pharmacology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Li LiuCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.ORCID 0000-0003-4002-7497
Bo NingDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0001-9437-7244
Zhongxing LiaoDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-2224-9478
Tony Y HuDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0001-7255-5409
The University of Texas MD Anderson Cancer Center · USTulane University · USArizona State University · USFrederick National Laboratory for Cancer Research · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Statistics, Data Exchange, Management and SupportP01CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DELANEY, THOMAS F · 1985 to 2013
$28.3M
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic CancerU01CA214254 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Ajay Goel, DANIEL D VON HOFF · 2017 to 2026
$8.9M
Direct quantitation of the circulating Mtb-peptidome for pediatric TB managementR01HD090927 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI Christopher J Lyon, Charles DeBeaux Mitchell · 2017 to 2026
$4.5M
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment MonitoringR01AI122932 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI HU, TONY Y. · 2016 to 2019
$1.8M
Real-time Detection of Active TB in HIV Exposed Children on CustomizedNanotrapR01AI113725 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI LABAER, JOSHUA · 2015 to 2018
$1.6M
Multiplexed quantification of circulating peptidomic signatures for EBOLA early diagnosisR21AI126361 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI LABAER, JOSHUA · 2017 to 2018
$373k
Quantitative diagnosis of TB/HIV co-infection using pathogen-specific exosomes in bloodR03AI140977 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FAN, JIA · 2018 to 2019
$154k
NCI NIH HHS P01 CA021239NCI NIH HHS P30 CA016672NCI NIH HHS U01 CA214254NIAID NIH HHS R01 AI113725NIAID NIH HHS R01 AI122932NIAID NIH HHS R03 AI140977NIAID NIH HHS R21 AI126361NICHD NIH HHS R01 HD090927
6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer and the leading cause of cancer death worldwide. More than half of patients with NSCLC die after developing distant metastases, so rapid, minimally invasive prognostic biomarkers are needed to reduce mortality. We used proteomics to identify proteins differentially expressed on extracellular vesicles (EVs) of nonmetastatic 393P and metastatic 344SQ NSCLC cell lines and found that tetraspanin-8 (Tspan8) was selectively enriched on 344SQ EVs. NSCLC cell lines treated with EVs overexpressing Tspan8 also exhibited increased Matrigel invasion. Elevated Tspan8 expression on serum EVs of individuals with stage III premetastatic NSCLC tumors was also associated with reduced distant metastasis-free survival, suggesting that Tspan8 levels on serum EVs may predict future metastasis. This result suggests that a minimally invasive blood test to analyze EV expression of Tspan8 may be of potential value to guide therapeutic decisions for patients with NSCLC and merits further study.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorExtracellular VesiclesHumansLung NeoplasmsMiceNeoplasm MetastasisNeoplasm ProteinsTetraspaninsNeoplasm ProteinsTetraspaninsTSPAN8 protein, human

Identifiers

PMID32195353
PMCPMC7065889
OpenAlexW3011050484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.